1. Search results in the navigational tree (All hits)
All the results are highlighted by color in the navigational tree
(at the left-hand side) and remain so until you click on a not highlighted menu item and
thus return to the usual content navigation.
In addition, you can browse through the search results consecutively by pressing the navigational buttons
(
<
1 of
63
>).
Within the text the search result is highlighted by color.
2. Search results by relevance (Top 5)
Following is a list of the 5 most important hits ranked by relevance.
Hint: In the
Help you will find explanations about using search operators in order to conduct an extended search.
Basic earnings per share are calculated by dividing the profit after tax attributable to the shareholders of Merck KGaA by the weighted average number of theoretical shares outstanding. The use of a theoretical number of shares takes into account the fact that the general partner’s capital is not represented by shares. The share capital of € 168.0 million was divided into 64,621,126 shares. Accordingly, the general partner’s capital of € 397.2 million was divided into 152,767,813 theoretical shares. Overall, the total capital thus amounted to € 565.2 million or 217,388,939 theoretical shares outstanding. The weighted average number of shares in 2013 was [...]
In 2013, the Merck share price rose by more than 30%, thus outperforming the DAX® by five percentage points. Merck shares were six percentage points stronger than the relevant pharmaceutical industry index and also outperformed the relevant chemical industry index by nearly 17 percentage points. Reaching an annual high of € 130.50 at the beginning of December 2013, Merck shares also hit a new all-time high, closing not far from this level at € 130.25 at the end of December 2013. The average daily trading volume decreased by 25%, from around 300,000 in 2012 to more than 230,000 shares in 2013. The North America region continued to dominate with around 43% of [...]
As of December 31, 2013, the members of the Executive Board and of the Supervisory Board either directly or indirectly held 13,692 shares of Merck KGaA. Their total ownership represents less than 1% of the issued shares of Merck KGaA. Transactions executed by members of the Executive Board and of the Supervisory Board are disclosed on the Merck website at Directors’ Dealings.
The following table presents the list of shareholdings of the Merck Group as of December 31, 2013. XLS Country Company Registered office Equity interest (%) thereof Merck KGaA (%) I. Fully consolidated companies Germany Germany Merck KGaA Darmstadt Parent company Germany AB Allgemeine Pensions GmbH & Co. KG Zossen 100.00 100.00 Germany Allergopharma GmbH & Co. KG Reinbek 100.00 Germany Allergopharma Verwaltungs GmbH Darmstadt 100.00 100.00 Germany Biochrom GmbH Berlin 100.00 Germany Chemische Fabrik Lehrte Dr. Andreas Kossel GmbH Lehrte 100.00 100.00 Germany Chemitra GmbH Darmstadt 100.00 100.00 Germany Emedia Export Company mbH Gernsheim 100.00 Germany [...]
XLS Share data1 2013 2012 1 Share-price relevant figures relate to the closing price in XETRA® trading on the Frankfurt Stock Exchange 2 Based on the floor trading systems of all German exchanges and the regulated market on XETRA® 3 Based on the theoretical number of shares (217.4 million) 4 Based on the number of shares in free float (64.6 million) Source: Bloomberg, Thomson Dividend / € 1.90 1.70 Share price high / € 130.50 106.55 Share price low / € 97.06 72.37 Year-end share price / € 130.25 99.83 Daily average number of Merck shares traded2 / in units 234,308 310,608 Market capitalization3 (at year-end) / € million 28,315 21,702 Market value of [...]
